Lone Peijs

Lone Peijs

Auto-generated profile, based on publicly available information

Lone Peijs

The Centre of Inflammation and Metabolism and Centre for Physical Activity Research Rigshospitalet, University Hospital of Copenhagen, 2100, Denmark; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Cell Metabolism
Verified
Journal Article
Closed access
NJNaja Zenius Jespersen
Naja Zenius Jespersen
TLTherese Juhlin Larsen
Therese Juhlin Larsen
LPLone Peijs
Lone Peijs
SDSøren Daugaard
Søren Daugaard
PHPreben Homøe
Preben Homøe
CSCamilla Scheele
Camilla Scheele

1 March 2015 in Cell Metabolism
Verified
Journal Article
Closed access
MKMichael J. Kraakman
Michael J. Kraakman
HKHelene L. Kammoun
Helene L. Kammoun
TATamara L. Allen
Tamara L. Allen
VDVirginie Deswaerte
Virginie Deswaerte
DHDarren C. Henstridge
Darren C. Henstridge
Mark A FebbraioMark A Febbraio
Mark A Febbraio

1 June 2019 in Molecular Metabolism
Verified
Journal Article
Open access
NJNaja Z. Jespersen
Naja Z. Jespersen
AFAmir Feizi
Amir Feizi
EAEline S. Andersen
Eline S. Andersen
SHSarah Heywood
Sarah Heywood
HHHelle B. Hattel
Helle B. Hattel
CSCamilla Scheele
Camilla Scheele
Increasing the amounts of functionally competent brown adipose tissue (BAT) in adult humans has the potential to restore dysfunctional metabolism and counteract obesity. In this study, we aimed to characterize the human perirenal fat depot, and we hypothesized that there would be regional, within-depot differences in the adipose signature depending on local sympathetic activity. We characterized fat specimens from four different perirenal regions of adult kidney donors, through a combination of qPCR mapping, immunohistochemical staining, RNA-sequencing, and pre-adipocyte isolation. Candidate gene signatures, separated by adipocyte morphology, were recapitulated in a murine model of unilocular brown fat induced by thermoneutrality and high fat diet. We identified widespread amounts of dormant brown adipose tissue throughout the perirenal depot, which was contrasted by multilocular BAT, primarily found near the adrenal gland. Dormant BAT was characterized by a unilocular morphology and a distinct gene expression profile, which partly overlapped with that of subcutaneous white adipose tissue (WAT). Brown fat precursor cells, which differentiated into functional brown adipocytes were present in the entire perirenal fat depot, regardless of state. We identified SPARC as a candidate adipokine contributing to a dormant BAT state, and CLSTN3 as a novel marker for multilocular BAT. We propose that perirenal adipose tissue in adult humans consists mainly of dormant BAT and provide a data set for future research on factors which can reactivate dormant BAT into active BAT, a potential strategy for combatting obesity and metabolic disease.

7 May 2013 in Endocrine
Verified
Journal Article
Closed access
PDF file
ARAnders Rinnov
Anders Rinnov
CYChristina Yfanti
Christina Yfanti
SNSøren Nielsen
Søren Nielsen
TÅThorbjörn C. A. Åkerström
Thorbjörn C. A. Åkerström
LPLone Peijs
Lone Peijs
BPBente Klarlund Pedersen
Bente Klarlund Pedersen

4 August 2015 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
KMKlaus Munkholm
Klaus Munkholm
LPL Peijs
L Peijs
MVMaj Vinberg
Maj Vinberg
LKL V Kessing
L V Kessing
Gene expression in peripheral blood has the potential to inform on pathophysiological mechanisms and has emerged as a viable avenue for the identification of biomarkers. Here, we aimed to identify gene expression candidate genes and to explore the potential for a composite gene expression measure as a diagnostic and state biomarker in bipolar disorder. First, messenger RNA levels of 19 candidate genes were assessed in peripheral blood mononuclear cells of 37 rapid cycling bipolar disorder patients in different affective states (depression, mania and euthymia) during a 6–12-month period and in 40 age- and gender-matched healthy control subjects. Second, a composite gene expression measure was constructed in the first half study sample and independently validated in the second half of the sample. We found downregulation of POLG and OGG1 expression in bipolar disorder patients compared with healthy control subjects. In patients with bipolar disorder, upregulation of NDUFV2 was observed in a depressed state compared with a euthymic state. The composite gene expression measure for discrimination between patients and healthy control subjects on the basis of 19 genes generated an area under the receiver-operating characteristic curve of 0.81 (P<0.0001) in sample 1, which was replicated with a value of 0.73 (P<0.0001) in sample 2, corresponding with a moderately accurate test. The present findings of altered POLG, OGG1 and NDUFV2 expression point to disturbances within mitochondrial function and DNA repair mechanisms in bipolar disorder. Further, a composite gene expression measure could hold promise as a potential diagnostic biomarker.

22 February 2017 in BMC Medicine
Verified
Journal Article
Open access
PDF file
CDCajsa Davegårdh
Cajsa Davegårdh
CBChrista Broholm
Christa Broholm
APAlexander Perfilyev
Alexander Perfilyev
THTora Henriksen
Tora Henriksen
SGSonia Garcia-Calzon
Sonia Garcia-Calzon
CLCharlotte Ling
Charlotte Ling
Human skeletal muscle stem cells are important for muscle regeneration. However, the combined genome-wide DNA methylation and expression changes taking place during adult myogenesis have not been described in detail and novel myogenic factors may be discovered. Additionally, obesity is associated with low relative muscle mass and diminished metabolism. Epigenetic alterations taking place during myogenesis might contribute to these defects. We used Infinium HumanMethylation450 BeadChip Kit (Illumina) and HumanHT-12 Expression BeadChip (Illumina) to analyze genome-wide DNA methylation and transcription before versus after differentiation of primary human myoblasts from 14 non-obese and 14 obese individuals. Functional follow-up experiments were performed using siRNA mediated gene silencing in primary human myoblasts and a transgenic mouse model. We observed genome-wide changes in DNA methylation and expression patterns during differentiation of primary human muscle stem cells (myoblasts). We identified epigenetic and transcriptional changes of myogenic transcription factors (MYOD1, MYOG, MYF5, MYF6, PAX7, MEF2A, MEF2C, and MEF2D), cell cycle regulators, metabolic enzymes and genes previously not linked to myogenesis, including IL32, metallothioneins, and pregnancy-specific beta-1-glycoproteins. Functional studies demonstrated IL-32 as a novel target that regulates human myogenesis, insulin sensitivity and ATP levels in muscle cells. Furthermore, IL32 transgenic mice had reduced insulin response and muscle weight. Remarkably, approximately 3.7 times more methylation changes (147,161 versus 39,572) were observed during differentiation of myoblasts from obese versus non-obese subjects. In accordance, DNMT1 expression increased during myogenesis only in obese subjects. Interestingly, numerous genes implicated in metabolic diseases and epigenetic regulation showed differential methylation and expression during differentiation only in obese subjects. Our study identifies IL-32 as a novel myogenic regulator, provides a comprehensive map of the dynamic epigenome during differentiation of human muscle stem cells and reveals abnormal epigenetic changes in obesity.